Search results for: Chronic Diseases
Filter search results
Viral Hepatitis in Britain
1 January 1977
…chronic liver disease, including chronic active hepatitis, cirrhosis and primary liver cancer. Hence hepatitis B presents quite different epidemiological problems from hepatitis A, and must also be regarded as a…
Comparing Access to Orphan Medicinal Products (OMPs) in the United Kingdom and other European countries
1 March 2017
The European Commission’s (EC) Orphan Medicinal Products Regulation intended to incentivise the research, development and marketing of new treatments for rare and chronically disabling or life-threatening diseases. Marketing authorisation granted…
Can a continued focus on prevention, diagnosis, and treatment see the NHS to another 75 years?
27 July 2023
…impact of the most significant diseases, from tuberculosis in the 1950s, to heart disease from the 1970s onwards, to cancer in this century. It did this through a consistent three-pronged…
Does Government Funding Increase Public Sector Development of New Medicines?
5 March 2021
…of research for medicines targeting rare diseases. To answer this question, a paper published last week by Dimitrios Kourouklis (2021), Senior Economist at OHE, quantifies the effect of public subsidies…
Priority Review Vouchers to Encourage Innovation for Neglected Diseases
1 January 2011
Priority Review Vouchers (PRVs) are awarded in the US to companies that gain approval there for a new drug for one of sixteen tropical diseases, under a law passed in…
Venereal Diseases
1 October 1974
The ‘venereal’ diseases of syphilis and gonorrhoea, whilst deserving close attention, do not constitute one of the major health problems of Britain today. In 1972, in England, about one man…
Public Private Partnerships for Research and Development: Medicines and Vaccines for Diseases of Poverty
1 December 2002
…to treat and ultimately eradicate the infectious diseases prevalent predominately in the poorest regions of the developing world. This book focuses on the role of public-private partnerships (PPPs) as an…
A Case Study Analysis: Challenges in the NICE Evaluation of Multi-Indication Medicines for Rare and Ultra-Rare Diseases
1 September 2021
…believe these changes to be encouraging but draw attention to potential shortcomings and areas that may still require improvement to ensure that patients with rare and ultra-rare diseases are treated…
Arthritis
1 March 1992
Arthritis is a common and chronic disease with over 200 conditions included in this category. It affects every tenth inhabitant of the world according to the World Health Organisation (Novosti…